Lynn M. Matrisian - Publications

Affiliations: 
Vanderbilt University, Nashville, TN 
Area:
Cell Biology, Oncology
Website:
https://business.vanderbilt.edu/stories/lynn-matrisian/

174 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Pishvaian MJ, Brody JR, Matrisian L, Hendifar AE, Engebretson A, Hoos WA, Mikhail S, Chung VM, Picozzi VJ, Ramos C, Heartwell C, Mason K, Varieur K, Rahib L, Petricoin E, et al. Multi-Omic profiling (MoP) for patients (pts) with pancreatic cancer (PDA): Initial results of the Know Your Tumor (KYT) initiative. Journal of Clinical Oncology. 34: 282-282. DOI: 10.1200/Jco.2016.34.4_Suppl.282  0.306
2016 Pishvaian MJ, Matrisian L, Hendifar AE, Engebretson A, Rahib L, Hoos WA, Mikhail S, Chung VM, Picozzi VJ, Heartwell C, Mason K, Varieur K, Madhavan S, Petricoin E, Brody JR. Preliminary observations of blood-based (BB) molecular testing in a subset of patients with pancreatic cancer (PDA) participating in the Know Your Tumor (KYT) initiative. Journal of Clinical Oncology. 34: 268-268. DOI: 10.1200/Jco.2016.34.4_Suppl.268  0.307
2015 Samuelson LE, Scherer RL, VanSaun MN, Fan KH, Dozier EA, Carter KJ, Koyama T, Shyr Y, Aschner M, Stanwood GD, Bornhop DJ, Matrisian LM, McIntyre JO. New tools for the quantitative assessment of prodrug delivery and neurotoxicity. Neurotoxicology. 47: 88-98. PMID 25732874 DOI: 10.1016/J.Neuro.2015.02.005  0.787
2014 Seeley EH, Wilson KJ, Yankeelov TE, Johnson RW, Gore JC, Caprioli RM, Matrisian LM, Sterling JA. Co-registration of multi-modality imaging allows for comprehensive analysis of tumor-induced bone disease. Bone. 61: 208-16. PMID 24487126 DOI: 10.1016/J.Bone.2014.01.017  0.358
2013 Samuelson LE, Scherer RL, Matrisian LM, McIntyre JO, Bornhop DJ. Synthesis and in vitro efficacy of MMP9-activated NanoDendrons. Molecular Pharmaceutics. 10: 3164-74. PMID 23750801 DOI: 10.1021/Mp4002206  0.848
2013 Lee IK, Vansaun MN, Shim JH, Matrisian LM, Gorden DL. Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer. The Journal of Surgical Research. 180: 252-9. PMID 22763216 DOI: 10.1016/J.Jss.2012.04.074  0.48
2012 Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM, Bhowmick NA. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Molecular Cancer Research : McR. 10: 494-503. PMID 22290877 DOI: 10.1158/1541-7786.Mcr-11-0506  0.347
2012 Thiolloy S, Edwards JR, Fingleton B, Rifkin DB, Matrisian LM, Lynch CC. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. Plos One. 7: e29862. PMID 22238668 DOI: 10.1371/Journal.Pone.0029862  0.804
2012 Mendonsa AM, Chalfant M, VanSaun MN, Matrisian L, Gorden DL. Abstract 389: MMP12 and myeloid cell populations influence establishment of tumor metastases in the steatotic liver microenvironment Cancer Research. 72: 389-389. DOI: 10.1158/1538-7445.Am2012-389  0.463
2011 Biswas S, Nyman JS, Alvarez J, Chakrabarti A, Ayres A, Sterling J, Edwards J, Rana T, Johnson R, Perrien DS, Lonning S, Shyr Y, Matrisian LM, Mundy GR. Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. Plos One. 6: e27090. PMID 22096521 DOI: 10.1371/Journal.Pone.0027090  0.35
2011 Gorden DL, Ivanova PT, Myers DS, McIntyre JO, VanSaun MN, Wright JK, Matrisian LM, Brown HA. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. Plos One. 6: e22775. PMID 21857953 DOI: 10.1371/journal.pone.0022775  0.342
2011 Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR, Sterling JA. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Research. 71: 822-31. PMID 21189326 DOI: 10.1158/0008-5472.Can-10-2993  0.41
2011 Li X, Sterling JA, Mundy GR, Hayward SW, Matrisian LM, Bhowmick NA. Abstract 527: Loss of TGF-β responsiveness in stromal cells of the prostate facilitates early prostate cancer bone lesion development Cancer Research. 71: 527-527. DOI: 10.1158/1538-7445.Am2011-527  0.321
2011 Thiolloy S, Edwards J, Fingleton B, Rifkin D, Schwartz HS, Mundy G, Matrisian LM, Lynch CC. Abstract 3112: Host MMP-2 impacts tumor survival in the metastatic bone microenvironment through a TGFβ dependent mechanism Cancer Research. 71: 3112-3112. DOI: 10.1158/1538-7445.Am2011-3112  0.798
2010 Bruni-Cardoso A, Lynch CC, Rosa-Ribeiro R, Matrisian LM, Carvalho HF. MMP-2 contributes to the development of the mouse ventral prostate by impacting epithelial growth and morphogenesis. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 239: 2386-92. PMID 20839326 DOI: 10.1002/Dvdy.22382  0.541
2010 Martin MD, Kremers GJ, Short KW, Rocheleau JV, Xu L, Piston DW, Matrisian LM, Gorden DL. Rapid extravasation and establishment of breast cancer micrometastases in the liver microenvironment. Molecular Cancer Research : McR. 8: 1319-27. PMID 20724460 DOI: 10.1158/1541-7786.Mcr-09-0551  0.389
2010 Lynch CC, Vargo-Gogola T, Matrisian LM, Fingleton B. Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. Journal of Oncology. 2010: 530745. PMID 20628524 DOI: 10.1155/2010/530745  0.785
2010 Uddin MJ, Crews BC, Blobaum AL, Kingsley PJ, Gorden DL, McIntyre JO, Matrisian LM, Subbaramaiah K, Dannenberg AJ, Piston DW, Marnett LJ. Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents. Cancer Research. 70: 3618-27. PMID 20430759 DOI: 10.1158/0008-5472.Can-09-2664  0.523
2010 McIntyre JO, Scherer RL, Matrisian LM. Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods in Molecular Biology (Clifton, N.J.). 622: 279-304. PMID 20135290 DOI: 10.1007/978-1-60327-299-5_18  0.836
2010 VanSaun MN, Mendonsa A, Lee IK, Matrisian LM, Gorden L. Abstract LB-378: Establishment of hepatic metastases in a steatotic microenvironment is enhanced by stromal derived MMP-12 Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-378  0.529
2010 Soebbing S, Tantawy MN, Baldwin RM, Peterson TE, Matrisian LM, McIntyre JO. Noninvasive in vivo imaging of MMP-7 activity Nuclear Medicine and Biology. 37: 708. DOI: 10.1016/J.Nucmedbio.2010.04.010  0.611
2009 Steeg PS, Anderson RL, Bar-Eli M, Chambers AF, Eccles SA, Hunter K, Itoh K, Kang Y, Matrisian LM, Sleeman JP, Theodorescu D, Thompson EW, Welch DR. An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4529. PMID 25278743 DOI: 10.1158/1078-0432.Ccr-09-1363  0.372
2009 Thiolloy S, Halpern J, Holt GE, Schwartz HS, Mundy GR, Matrisian LM, Lynch CC. Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. Cancer Research. 69: 6747-55. PMID 19679556 DOI: 10.1158/0008-5472.Can-08-3949  0.852
2009 McIntyre JO, Matrisian LM. Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity. Methods in Molecular Biology (Clifton, N.J.). 539: 155-74. PMID 19377965 DOI: 10.1007/978-1-60327-003-8_9  0.654
2008 Sinnamon MJ, Carter KJ, Fingleton B, Matrisian LM. Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. International Journal of Experimental Pathology. 89: 466-75. PMID 19134056 DOI: 10.1111/J.1365-2613.2008.00621.X  0.839
2008 Scherer RL, VanSaun MN, McIntyre JO, Matrisian LM. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Molecular Imaging. 7: 118-31. PMID 19123982 DOI: 10.2310/7290.2008.00010  0.844
2008 McCawley LJ, Wright J, LaFleur BJ, Crawford HC, Matrisian LM. Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment. The American Journal of Pathology. 173: 1528-39. PMID 18832569 DOI: 10.2353/Ajpath.2008.080132  0.762
2008 Martin MD, Fingleton B, Lynch CC, Wells S, McIntyre JO, Piston DW, Matrisian LM. Establishment and quantitative imaging of a 3D lung organotypic model of mammary tumor outgrowth. Clinical & Experimental Metastasis. 25: 877-85. PMID 18787962 DOI: 10.1007/S10585-008-9206-Y  0.555
2008 Quarles CC, Lepage M, Gorden DL, Fingleton B, Yankeelov TE, Price RR, Matrisian LM, Gore JC, McIntyre JO. Functional colonography of Min mice using dark lumen dynamic contrast-enhanced MRI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 718-26. PMID 18727087 DOI: 10.1002/Mrm.21724  0.472
2008 Martin MD, Carter KJ, Jean-Philippe SR, Chang M, Mobashery S, Thiolloy S, Lynch CC, Matrisian LM, Fingleton B. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Research. 68: 6251-9. PMID 18676849 DOI: 10.1158/0008-5472.Can-08-0537  0.853
2008 Macias-Perez I, Borza C, Chen X, Yan X, Ibanez R, Mernaugh G, Matrisian LM, Zent R, Pozzi A. Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer. Cancer Research. 68: 6127-35. PMID 18676835 DOI: 10.1158/0008-5472.Can-08-1395  0.404
2008 Scherer RL, McIntyre JO, Matrisian LM. Imaging matrix metalloproteinases in cancer. Cancer Metastasis Reviews. 27: 679-90. PMID 18465089 DOI: 10.1007/S10555-008-9152-9  0.849
2008 Sinnamon MJ, Carter KJ, Sims LP, Lafleur B, Fingleton B, Matrisian LM. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis. 29: 880-6. PMID 18258601 DOI: 10.1093/Carcin/Bgn040  0.795
2008 Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC, Moses HL. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell. 13: 23-35. PMID 18167337 DOI: 10.1016/J.Ccr.2007.12.004  0.355
2008 Thiolloy S, Lynch C, Fingleton B, Mundy G, Matrisian L. P37. The in vivo impact of host MMP-2 to mammary tumor growth induced osteolysis Cancer Treatment Reviews. 34: 27. DOI: 10.1016/J.Ctrv.2008.03.079  0.824
2008 Edwards C, Lynch C, Fowler J, Carter K, Lwin S, Matrisian L, Mundy G. P22. Host-derived MMP9 promotes progression of multiple myeloma in vivo Cancer Treatment Reviews. 34: 21. DOI: 10.1016/J.Ctrv.2008.03.064  0.464
2008 Edwards CM, Lynch CC, Fowler JA, Carter K, Lwin ST, Matrisian LM, Mundy GR. Differential effects of host-derived mmps on development of multiple myeloma in vivo Bone. 42: S94. DOI: 10.1016/J.Bone.2007.12.179  0.473
2008 Dive V, Paulick MG, McIntyre JO, Matrisian LM, Bogyo M. Activity-based imaging and biochemical profiling tools for analysis of the cancer degradome The Cancer Degradome: Proteases and Cancer Biology. 101-135. DOI: 10.1007/978-0-387-69057-5_7  0.388
2007 Lepage M, Dow WC, Melchior M, You Y, Fingleton B, Quarles CC, Pépin C, Gore JC, Matrisian LM, McIntyre JO. Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch. Molecular Imaging. 6: 393-403. PMID 18053410 DOI: 10.2310/7290.2007.00035  0.645
2007 López-Otín C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nature Reviews. Cancer. 7: 800-8. PMID 17851543 DOI: 10.1038/Nrc2228  0.343
2007 Martin MD, Matrisian LM. The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Reviews. 26: 717-24. PMID 17717634 DOI: 10.1007/S10555-007-9089-4  0.589
2007 Lynch CC, Vargo-Gogola T, Martin MD, Fingleton B, Crawford HC, Matrisian LM. Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Cancer Research. 67: 6760-7. PMID 17638887 DOI: 10.1158/0008-5472.Can-07-0026  0.848
2007 Fingleton B, Carter KJ, Matrisian LM. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model. Cancer Research. 67: 4800-6. PMID 17510409 DOI: 10.1158/0008-5472.Can-06-4473  0.416
2007 Schwartz DR, Moin K, Yao B, Matrisian LM, Coussens LM, Bugge TH, Fingleton B, Acuff HB, Sinnamon M, Nassar H, Platts AE, Krawetz SA, Linebaugh BE, Sloane BF. Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment. Molecular Cancer Research : McR. 5: 443-54. PMID 17510311 DOI: 10.1158/1541-7786.Mcr-06-0337  0.779
2007 Gorden DL, Fingleton B, Crawford HC, Jansen DE, Lepage M, Matrisian LM. Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment. International Journal of Cancer. 121: 495-500. PMID 17417772 DOI: 10.1002/Ijc.22594  0.746
2007 Nicoud IB, Jones CM, Pierce JM, Earl TM, Matrisian LM, Chari RS, Gorden DL. Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction. Cancer Research. 67: 2720-8. PMID 17363593 DOI: 10.1158/0008-5472.Can-06-3923  0.492
2007 Fingleton B, Powell WC, Crawford HC, Couchman JR, Matrisian LM. A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo. Hybridoma (2005). 26: 22-7. PMID 17316082 DOI: 10.1089/Hyb.2006.028  0.699
2007 Piston D, Uddin M, McIntyre J, Crews B, Head W, Wells K, Matrisian L, Marnett L. Quantitative Optical Imaging of Molecular Signals from Cancerous Cells in vivo Microscopy and Microanalysis. 13. DOI: 10.1017/S1431927607072819  0.47
2006 Halpern J, Lynch CC, Fleming J, Hamming D, Martin MD, Schwartz HS, Matrisian LM, Holt GE. The application of a murine bone bioreactor as a model of tumor: bone interaction. Clinical & Experimental Metastasis. 23: 345-56. PMID 17136574 DOI: 10.1007/S10585-006-9044-8  0.315
2006 Taylor JL, Hattle JM, Dreitz SA, Troudt JM, Izzo LS, Basaraba RJ, Orme IM, Matrisian LM, Izzo AA. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infection and Immunity. 74: 6135-44. PMID 16982845 DOI: 10.1128/Iai.02048-05  0.504
2006 Acuff HB, Sinnamon M, Fingleton B, Boone B, Levy SE, Chen X, Pozzi A, Carbone DP, Schwartz DR, Moin K, Sloane BF, Matrisian LM. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Research. 66: 7968-75. PMID 16912171 DOI: 10.1158/0008-5472.Can-05-4279  0.834
2006 Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation. 113: 2919-28. PMID 16769909 DOI: 10.1161/Circulationaha.106.612960  0.527
2006 Menon R, McIntyre JO, Matrisian LM, Fortunato SJ. Salivary proteinase activity: a potential biomarker for preterm premature rupture of the membranes. American Journal of Obstetrics and Gynecology. 194: 1609-15; discussion . PMID 16731078 DOI: 10.1016/J.Ajog.2006.02.052  0.427
2006 Qin X, Corriere MA, Matrisian LM, Guzman RJ. Matrix metalloproteinase inhibition attenuates aortic calcification. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1510-6. PMID 16690876 DOI: 10.1161/01.ATV.0000225807.76419.a7  0.396
2006 VanSaun MN, Matrisian LM. Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Research. Part C, Embryo Today : Reviews. 78: 69-79. PMID 16622849 DOI: 10.1002/Bdrc.20061  0.511
2006 Zhang W, Matrisian LM, Holmbeck K, Vick CC, Rosenthal EL. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. Bmc Cancer. 6: 52. PMID 16515711 DOI: 10.1186/1471-2407-6-52  0.562
2006 Rosenthal EL, Matrisian LM. Matrix metalloproteases in head and neck cancer. Head & Neck. 28: 639-48. PMID 16470875 DOI: 10.1002/Hed.20365  0.589
2006 Acuff HB, Carter KJ, Fingleton B, Gorden DL, Matrisian LM. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Research. 66: 259-66. PMID 16397239 DOI: 10.1158/0008-5472.Can-05-2502  0.855
2006 Thiolloy S, Lynch CC, Martin MM, Fingleton B, Matrisian LM. Mammary tumor-induced osteolysis involved stromal MMP-2 and MMP-9 Matrix Biology. 25. DOI: 10.1016/J.Matbio.2006.08.135  0.851
2006 MATRISIAN L, MCCAWLEY L, LYNCH C. The complex biology of matrix metalloproteinases Matrix Biology. 25: S5-S6. DOI: 10.1016/j.matbio.2006.08.017  0.315
2005 Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R, Pozzi A. An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice. Clinical & Experimental Metastasis. 22: 185-93. PMID 16086239 DOI: 10.1007/S10585-005-7453-8  0.852
2005 Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell. 7: 485-96. PMID 15894268 DOI: 10.1016/J.Ccr.2005.04.013  0.821
2005 Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R, Pozzi A. Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. International Journal of Cancer. 116: 52-61. PMID 15756690 DOI: 10.1002/Ijc.20997  0.855
2005 Gjertsson I, Innocenti M, Matrisian LM, Tarkowski A. Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microbial Pathogenesis. 38: 97-105. PMID 15748811 DOI: 10.1016/J.MICPATH.2004.12.005  0.444
2005 Harrell PC, McCawley LJ, Fingleton B, McIntyre JO, Matrisian LM. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Experimental Cell Research. 303: 308-20. PMID 15652345 DOI: 10.1016/J.Yexcr.2004.09.020  0.81
2004 Fingleton B, Menon R, Carter KJ, Overstreet PD, Hachey DL, Matrisian LM, McIntyre JO. Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7865-74. PMID 15585619 DOI: 10.1158/1078-0432.Ccr-04-1252  0.528
2004 Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, Matrisian LM, Carbone DP, Lin PC. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 6: 409-21. PMID 15488763 DOI: 10.1016/J.Ccr.2004.08.031  0.476
2004 McCawley LJ, Crawford HC, King LE, Mudgett J, Matrisian LM. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Research. 64: 6965-72. PMID 15466188 DOI: 10.1158/0008-5472.Can-04-0910  0.748
2004 Gustavson MD, Crawford HC, Fingleton B, Matrisian LM. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Molecular Carcinogenesis. 41: 125-39. PMID 15457508 DOI: 10.1002/Mc.20049  0.787
2004 Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, Khokha R. Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nature Genetics. 36: 969-77. PMID 15322543 DOI: 10.1038/Ng1413  0.341
2004 Kundranda MN, Ray S, Saria M, Friedman D, Matrisian LM, Lukyanov P, Ochieng J. Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A. Biochimica Et Biophysica Acta. 1693: 111-23. PMID 15313013 DOI: 10.1016/J.Bbamcr.2004.06.005  0.342
2004 Leite-Browning ML, McCawley LJ, Jahnen-Dechent W, King LE, Matrisian LM, Ochieng J. Alpha 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis. International Journal of Oncology. 25: 319-24. PMID 15254728 DOI: 10.3892/Ijo.25.2.319  0.415
2004 Hulboy DL, Gautam S, Fingleton B, Matrisian LM. The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse. Oncology Reports. 12: 13-7. PMID 15201952 DOI: 10.3892/Or.12.1.13  0.591
2004 Lynch CC, Crawford HC, Matrisian LM, McDonnell S. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors. International Journal of Oncology. 24: 1565-72. PMID 15138601 DOI: 10.3892/Ijo.24.6.1565  0.694
2004 DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. The American Journal of Pathology. 164: 1131-9. PMID 15039201 DOI: 10.1016/S0002-9440(10)63200-2  0.489
2004 Wagenaar-Miller RA, Gorden L, Matrisian LM. Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Reviews. 23: 119-35. PMID 15000153 DOI: 10.1023/A:1025819214508  0.851
2004 McIntyre JO, Fingleton B, Wells KS, Piston DW, Lynch CC, Gautam S, Matrisian LM. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. The Biochemical Journal. 377: 617-28. PMID 14556651 DOI: 10.1042/Bj20030582  0.621
2003 McIntyre JO, Matrisian LM. Molecular imaging of proteolytic activity in cancer. Journal of Cellular Biochemistry. 90: 1087-97. PMID 14635184 DOI: 10.1002/Jcb.10713  0.547
2003 Matrisian LM, Sledge GW, Mohla S. Extracellular proteolysis and cancer: meeting summary and future directions. Cancer Research. 63: 6105-9. PMID 14559785  0.306
2003 Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology. 125: 1125-36. PMID 14517796 DOI: 10.1016/S0016-5085(03)01206-X  0.661
2003 Filippov S, Caras I, Murray R, Matrisian LM, Chapman HA, Shapiro S, Weiss SJ. Matrilysin-dependent elastolysis by human macrophages. The Journal of Experimental Medicine. 198: 925-35. PMID 12963695 DOI: 10.1084/Jem.20030626  0.499
2003 Rivat C, Le Floch N, Sabbah M, Teyrol I, Redeuilh G, Bruyneel E, Mareel M, Matrisian LM, Crawford HC, Gespach C, Attoub S. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1721-3. PMID 12958188 DOI: 10.1096/Fj.03-0132Fje  0.707
2003 Wagenaar-Miller RA, Hanley G, Shattuck-Brandt R, DuBois RN, Bell RL, Matrisian LM, Morgan DW. Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. British Journal of Cancer. 88: 1445-52. PMID 12778076 DOI: 10.1038/Sj.Bjc.6600867  0.836
2003 Kure T, Chang JH, Kato T, Hernández-Quintela E, Ye H, Lu PC, Matrisian LM, Gatinel D, Shapiro S, Gosheh F, Azar DT, Gosheh F. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Investigative Ophthalmology & Visual Science. 44: 137-44. PMID 12506066 DOI: 10.1167/Iovs.01-1058  0.375
2003 Escobar G, Hendrick JW, Leiser JS, Sample JA, Dowdy KB, Sweterlitsch SE, Mingoia JT, Matrisian LM, Lindsey ML. MMP-7 deletion improves survival post-MI Journal of Cardiac Failure. 9: S15. DOI: 10.1016/S1071-9164(03)00288-4  0.45
2002 Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation; Research in Biological Diversity. 70: 561-73. PMID 12492497 DOI: 10.1046/J.1432-0436.2002.700909.X  0.609
2002 Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Archives of Biochemistry and Biophysics. 408: 155-61. PMID 12464266 DOI: 10.1016/S0003-9861(02)00525-8  0.83
2002 Leite-Browning ML, McCawley LJ, Choi OH, Matrisian LM, Ochieng J. Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells. International Journal of Oncology. 21: 965-71. PMID 12370742  0.446
2002 Vargo-Gogola T, Fingleton B, Crawford HC, Matrisian LM. Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Cancer Research. 62: 5559-63. PMID 12359768  0.785
2002 Newell KJ, Matrisian LM, Driman DK. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Molecular Carcinogenesis. 34: 59-63. PMID 12112311 DOI: 10.1002/Mc.10049  0.445
2002 Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. The Journal of Clinical Investigation. 109: 1437-44. PMID 12045257 DOI: 10.1172/Jci15051  0.706
2002 Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nature Reviews. Molecular Cell Biology. 3: 207-14. PMID 11994741 DOI: 10.1038/Nrm763  0.506
2002 Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (New York, N.Y.). 295: 2387-92. PMID 11923519 DOI: 10.1126/Science.1067100  0.522
2002 Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia (New York, N.Y.). 3: 459-68. PMID 11774028 DOI: 10.1038/Sj.Neo.7900190  0.82
2001 Fingleton B, Matrisian LM. Matrix metalloproteinases as targets for therapy in Kaposi sarcoma. Current Opinion in Oncology. 13: 368-73. PMID 11555714 DOI: 10.1097/00001622-200109000-00009  0.416
2001 McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Current Opinion in Cell Biology. 13: 534-40. PMID 11544020 DOI: 10.1016/S0955-0674(00)00248-9  0.485
2001 Hulboy DL, Matrisian LM, Crawford HC. Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors. Molecular and Cellular Biology. 21: 5478-87. PMID 11463830 DOI: 10.1128/Mcb.21.16.5478-5487.2001  0.606
2001 Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). The Journal of Biological Chemistry. 276: 28261-7. PMID 11375993 DOI: 10.1074/Jbc.M103608200  0.732
2001 Brantley DM, Chen CL, Muraoka RS, Bushdid PB, Bradberry JL, Kittrell F, Medina D, Matrisian LM, Kerr LD, Yull FE. Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Molecular Biology of the Cell. 12: 1445-55. PMID 11359934 DOI: 10.1091/Mbc.12.5.1445  0.38
2001 McCawley LJ, Matrisian LM. Tumor progression: defining the soil round the tumor seed. Current Biology : Cb. 11: R25-7. PMID 11166192 DOI: 10.1016/S0960-9822(00)00038-5  0.487
2001 Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA, Matrisian LM. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Molecular and Cellular Biology. 21: 1370-83. PMID 11158322 DOI: 10.1128/Mcb.21.4.1370-1383.2001  0.809
2000 Matrisian LM. Quick guide. Matrix metalloproteinases. Current Biology : Cb. 10: R692. PMID 11050400 DOI: 10.1016/S0960-9822(00)00720-X  0.383
2000 Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Molecular and Cellular Biology. 20: 5828-39. PMID 10913166 DOI: 10.1128/Mcb.20.16.5828-5839.2000  0.616
2000 Rudolph-Owen LA, Matrisian LM. Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland. Journal of Mammary Gland Biology and Neoplasia. 3: 177-89. PMID 10819526 DOI: 10.1023/A:1018746923474  0.529
2000 McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Molecular Medicine Today. 6: 149-56. PMID 10740253 DOI: 10.1016/S1357-4310(00)01686-5  0.523
2000 Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 1135-49. PMID 10694567 DOI: 10.1200/Jco.2000.18.5.1135  0.582
2000 Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. The Journal of Clinical Investigation. 105: 143-50. PMID 10642592 DOI: 10.1172/Jci7091  0.679
2000 Haro H, Crawford HC, Fingleton B, MacDougall JR, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. The Journal of Clinical Investigation. 105: 133-41. PMID 10642591 DOI: 10.1172/Jci7090  0.703
1999 Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Current Biology : Cb. 9: 1441-7. PMID 10607586 DOI: 10.1016/S0960-9822(00)80113-X  0.37
1999 Matrisian LM. Cancer biology: extracellular proteinases in malignancy. Current Biology : Cb. 9: R776-8. PMID 10531025 DOI: 10.1016/S0960-9822(00)80011-1  0.522
1999 Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, López-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM, Parks WC. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science (New York, N.Y.). 286: 113-7. PMID 10506557 DOI: 10.1126/Science.286.5437.113  0.32
1999 Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L, Boyd D, Nicolson G, Montana S. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Annals of the New York Academy of Sciences. 878: 212-27. PMID 10415733 DOI: 10.1111/J.1749-6632.1999.Tb07687.X  0.463
1999 Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene. 18: 2883-91. PMID 10362259 DOI: 10.1038/Sj.Onc.1202627  0.62
1999 Shattuck-Brandt RL, Lamps LW, Heppner Goss KJ, DuBois RN, Matrisian LM. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Molecular Carcinogenesis. 24: 177-87. PMID 10204802 DOI: 10.1002/(Sici)1098-2744(199903)24:3<177::Aid-Mc4>3.0.Co;2-6  0.433
1999 Fingleton BM, Heppner Goss KJ, Crawford HC, Matrisian LM. Matrilysin in early stage intestinal tumorigenesis. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 107: 102-10. PMID 10190286 DOI: 10.1111/J.1699-0463.1999.Tb01532.X  0.725
1998 Rudolph-Owen LA, Slayden OD, Matrisian LM, Brenner RM. Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients. Biology of Reproduction. 59: 1349-59. PMID 9828178 DOI: 10.1095/Biolreprod59.6.1349  0.533
1998 Goss KJH, Brown PD, Matrisian LM. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis. International Journal of Cancer. 78: 629-635. PMID 9808534 DOI: 10.1002/(Sici)1097-0215(19981123)78:5<629::Aid-Ijc17>3.0.Co;2-8  0.613
1998 Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian LM, Welgus HG, Parks WC. Matrilysin expression and function in airway epithelium. The Journal of Clinical Investigation. 102: 1321-31. PMID 9769324 DOI: 10.1172/Jci1516  0.407
1998 Rudolph-Owen LA, Cannon P, Matrisian LM. Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility. Molecular Biology of the Cell. 9: 421-35. PMID 9450965 DOI: 10.1091/Mbc.9.2.421  0.441
1997 Rudolph-Owen LA, Hulboy DL, Wilson CL, Mudgett J, Matrisian LM. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology. 138: 4902-11. PMID 9348221 DOI: 10.1210/Endo.138.11.5478  0.512
1997 Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. Journal of the National Cancer Institute. 89: 1260-70. PMID 9293916 DOI: 10.1093/Jnci/89.17.1260  0.587
1997 Dong Z, Crawford HC, Lavrovsky V, Taub D, Watts R, Matrisian LM, Colburn NH. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol- 13-acetate-induced invasion in mouse keratinocytes Molecular Carcinogenesis. 19: 204-212. PMID 9254887 DOI: 10.1002/(Sici)1098-2744(199707)19:3<204::Aid-Mc8>3.0.Co;2-D  0.682
1997 Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Molecular Human Reproduction. 3: 27-45. PMID 9239706 DOI: 10.1093/MOLEHR/3.1.27  0.319
1997 Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. The Journal of Clinical Investigation. 99: 2851-7. PMID 9185507 DOI: 10.1172/Jci119478  0.469
1997 Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proceedings of the National Academy of Sciences of the United States of America. 94: 1402-7. PMID 9037065 DOI: 10.1073/Pnas.94.4.1402  0.597
1997 Brenner RM, Rudolph L, Matrisian L, Slayden OD. Non-human primate models; artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts. Human Reproduction (Oxford, England). 150-64. PMID 8982757 DOI: 10.1093/Humrep/11.Suppl_2.150  0.479
1996 Knox JD, Boreham DR, Walker JA, Morrison DP, Matrisian LM, Nagle RB, Bowden GT. Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21-->q22. Cytogenetics and Cell Genetics. 72: 179-82. PMID 8978768 DOI: 10.1159/000134181  0.302
1996 Powell WC, Domann FE, Mitchen JM, Matrisian LM, Nagle RB, Bowden GT. Matrilysin expression in the involuting rat ventral prostate. The Prostate. 29: 159-68. PMID 8827084 DOI: 10.1002/1097-0045(199609)29:3<159::Aid-Pros2990290304>3.0.Co;2-L  0.421
1996 Powell WC, Matrisian LM. Complex roles of matrix metalloproteinases in tumor progression. Current Topics in Microbiology and Immunology. 1-21. PMID 8814982 DOI: 10.1007/978-3-642-61107-0_1  0.399
1996 Crawford HC, Matrisian LM. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme & Protein. 49: 20-37. PMID 8796995 DOI: 10.1159/000468614  0.675
1996 Witty JP, Foster SA, Stricklin GP, Matrisian LM, Stern PH. Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 11: 72-8. PMID 8770699 DOI: 10.1002/Jbmr.5650110111  0.311
1996 Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. The International Journal of Biochemistry & Cell Biology. 28: 123-36. PMID 8729000 DOI: 10.1016/1357-2725(95)00121-2  0.565
1996 Gaire M, Barro CD, Kerr LD, Carlisle F, Matrisian LM. Protein kinase C isotypes required for phorbol-ester induction of stromelysin-1 in rat fibroblasts. Molecular Carcinogenesis. 15: 124-33. PMID 8599579 DOI: 10.1002/(Sici)1098-2744(199602)15:2<124::Aid-Mc5>3.0.Co;2-J  0.37
1995 MacDougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer and Metastasis Reviews. 14: 351-362. PMID 8821095 DOI: 10.1007/Bf00690603  0.564
1995 Witty JP, Wright JH, Matrisian LM. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Molecular Biology of the Cell. 6: 1287-303. PMID 8573787 DOI: 10.1091/Mbc.6.10.1287  0.474
1995 DeSouza S, Lochner J, Machida CM, Matrisian LM, Ciment G. A novel nerve growth factor-responsive element in the stromelysin-1 (transin) gene that is necessary and sufficient for gene expression in PC12 cells Journal of Biological Chemistry. 270: 9106-9114. PMID 7721824 DOI: 10.1074/Jbc.270.16.9106  0.305
1995 Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM, Osteen KG. Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium Proceedings of the National Academy of Sciences of the United States of America. 92: 7362-7366. PMID 7638197 DOI: 10.1073/Pnas.92.16.7362  0.483
1995 Wilson CL, Heppner KJ, Rudolph LA, Matrisian LM. The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Molecular Biology of the Cell. 6: 851-69. PMID 7579699 DOI: 10.1091/Mbc.6.7.851  0.405
1994 Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells Proceedings of the National Academy of Sciences of the United States of America. 91: 609-613. PMID 8290571 DOI: 10.1073/Pnas.91.2.609  0.358
1994 Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. The Journal of Clinical Investigation. 94: 946-53. PMID 8083380 DOI: 10.1172/Jci117461  0.459
1994 Wright JH, McDonnell S, Portella G, Bowden GT, Balmain A, Matrisian LM. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Molecular Carcinogenesis. 10: 207-15. PMID 8068181 DOI: 10.1002/Mc.2940100405  0.442
1994 Newell KJ, Witty JP, Rodgers WH, Matrisian LM. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Molecular Carcinogenesis. 10: 199-206. PMID 8068180 DOI: 10.1002/Mc.2940100404  0.455
1994 Matrisian LM, Gaire M, Rodgers WH, Osteen KG. Metalloproteinase expression and hormonal regulation during tissue remodeling in the cycling human endometrium. Contributions to Nephrology. 107: 94-100. PMID 8004979 DOI: 10.1159/000422966  0.329
1994 Matrisian LM. Matrix metalloproteinase gene expression. Annals of the New York Academy of Sciences. 732: 42-50. PMID 7978826 DOI: 10.1111/J.1749-6632.1994.Tb24723.X  0.441
1994 Ennis BW, Matrisian LM. Matrix degrading metalloproteinases. Journal of Neuro-Oncology. 18: 105-9. PMID 7964973 DOI: 10.1007/Bf01050416  0.432
1994 Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proceedings of the National Academy of Sciences of the United States of America. 91: 10129-33. PMID 7937850 DOI: 10.1073/Pnas.91.21.10129  0.426
1993 Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. American Journal of Obstetrics and Gynecology. 168: 253-60. PMID 8420336 DOI: 10.1016/S0002-9378(12)90922-9  0.507
1992 Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends in Genetics : Tig. 6: 121-5. PMID 2132731 DOI: 10.1016/0168-9525(90)90126-Q  0.462
1992 McDonnell S, Navre M, Coffey RJ, Matrisian LM. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Molecular Carcinogenesis. 4: 527-33. PMID 1793490 DOI: 10.1002/Mc.2940040617  0.525
1992 Matrisian LM, Ganser GL, Kerr LD, Pelton RW, Wood LD. Negative regulation of gene expression by TGF-beta. Molecular Reproduction and Development. 32: 111-20. PMID 1637549 DOI: 10.1002/Mrd.1080320206  0.365
1992 Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 14: 455-463. PMID 1445287 DOI: 10.1002/Bies.950140705  0.511
1991 McDonnell S, Matrisian LM. Stromelysin in tumor progression and metastasis. Cancer Metastasis Reviews. 9: 305-19. PMID 2097083 DOI: 10.1007/Bf00049521  0.497
1991 Matrisian LM, McDonnell S, Miller DB, Navre M, Seftor EA, Hendrix MJ. The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. The American Journal of the Medical Sciences. 302: 157-62. PMID 1928226 DOI: 10.1097/00000441-199109000-00008  0.457
1990 Machida CM, Rodland KD, Matrisian L, Magun BE, Ciment G. NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells. Neuron. 2: 1587-96. PMID 2560648 DOI: 10.1016/0896-6273(89)90047-0  0.597
1990 Matrisian LM, Hogan BL. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development Current Topics in Developmental Biology. 24: 219-259. PMID 2199157 DOI: 10.1016/S0070-2153(08)60089-7  0.444
1989 Ostrowski LE, Finch J, Krieg P, Matrisian L, Patskan G, O'Connell JF, Phillips J, Slaga TJ, Breathnach R, Bowden GT. Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression. Molecular Carcinogenesis. 1: 13-9. PMID 3151258 DOI: 10.1002/Mc.2940010106  0.372
1989 Kerr LD, Holt JT, Matrisian LM. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science (New York, N.Y.). 242: 1424-7. PMID 2462278 DOI: 10.1126/Science.2462278  0.307
1987 Matrisian LM, Bowden GT, Krieg P, Fürstenberger G, Briand JP, Leroy P, Breathnach R. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proceedings of the National Academy of Sciences of the United States of America. 83: 9413-7. PMID 3540938 DOI: 10.1073/Pnas.83.24.9413  0.336
1987 Matrisian LM, Davis D, Magun BE. Internalization and processing of epidermal growth factor in aging human fibroblasts in culture. Experimental Gerontology. 22: 81-9. PMID 3497817 DOI: 10.1016/0531-5565(87)90043-X  0.571
1987 Thornburg W, Rao RK, Matrisian LM, Magun BE, Koldovský O. Effect of maturation on gastrointestinal absorption of epidermal growth factor in rats. The American Journal of Physiology. 253: G68-71. PMID 3496799 DOI: 10.1152/AJPGI.1987.253.1.G68  0.545
1986 Rao RK, Thornburg W, Korc M, Matrisian LM, Magun BE, Koldovský O. Processing of epidermal growth factor by suckling and adult rat intestinal cells. The American Journal of Physiology. 250: G850-5. PMID 3521322 DOI: 10.1152/Ajpgi.1986.250.6.G850  0.567
1985 Matrisian LM, Rautmann G, Magun BE, Breathnach R. Epidermal growth factor or serum stimulation of rat fibroblasts induces an elevation in mRNA levels for lactate dehydrogenase and other glycolytic enzymes. Nucleic Acids Research. 13: 711-26. PMID 3873645 DOI: 10.1093/NAR/13.3.711  0.538
1985 Matrisian LM, Planck SR, Finch JS, Magun BE. Heterogeneity of 125I-labeled epidermal growth factor Bba - General Subjects. 839: 139-146. PMID 3872683 DOI: 10.1016/0304-4165(85)90030-3  0.555
1984 Widelitz RB, Matrisian LM, Russell DH, Magun BE. Differential effects of lysosomotropic amines and polyamines on processing and biological activity of EGF Experimental Cell Research. 155: 163-170. PMID 6333348 DOI: 10.1016/0014-4827(84)90777-8  0.582
1984 Russell DH, Matrisian L, Kibler R, Larson DF, Poulos B, Magun BE. Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochemical and Biophysical Research Communications. 121: 899-906. PMID 6331435 DOI: 10.1016/0006-291X(84)90762-9  0.55
1984 Korc M, Matrisian LM, Magun BE. Cytosolic calcium regulates epidermal growth factor endocytosis in rat pancreas and cultured fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 81: 461-5. PMID 6320188 DOI: 10.1073/Pnas.81.2.461  0.583
1984 Korc M, Matrisian LM, Nakamura R, Magun BE. Epidermal growth factor binding is altered in pancreatic acini from diabetic rats. Life Sciences. 35: 2049-55. PMID 6092811 DOI: 10.1016/0024-3205(84)90562-9  0.535
1983 Matrisian LM, Larsen BR, Finch JS, Magun BE. Further purification of epidermal growth factor by high-performance liquid chromatography. Analytical Biochemistry. 125: 339-51. PMID 6983841 DOI: 10.1016/0003-2697(82)90015-X  0.521
1983 Korc M, Matrisian LM, Magun BE. Direct modulation of epidermal growth factor binding by cholecystokinin. Life Sciences. 33: 561-8. PMID 6310297 DOI: 10.1016/0024-3205(83)90131-5  0.569
1983 Korc M, Matrisian LM, Planck SR, Magun BE. Binding of epidermal growth factor in rat pancreatic acini Biochemical and Biophysical Research Communications. 111: 1066-1073. PMID 6301480 DOI: 10.1016/0006-291X(83)91408-0  0.545
1983 Pathak MA, Matrisian LM, Magun BE, Salmon SE. Effect of epidermal growth factor on clonogenic growth of primary human tumor cells. International Journal of Cancer. 30: 745-50. PMID 6298120 DOI: 10.1002/Ijc.2910300611  0.624
1982 Matrisian LM, Pathak M, Magun BE. Identification of an epidermal growth factor-related transforming growth factor from rat fetuses Biochemical and Biophysical Research Communications. 107: 761-769. PMID 6982709 DOI: 10.1016/0006-291X(82)90589-7  0.554
1982 Magun BE, Planck SR, Matrisian LM, Finch JS. Binding, internalization and intracellular processing of 125I-epidermal growth factor purified by isoelectric focusing Biochemical and Biophysical Research Communications. 108: 299-306. PMID 6293485 DOI: 10.1016/0006-291X(82)91866-6  0.576
1981 Matrisian LM, Bowden GT, Magun BE. Mechanism of synergistic induction of DNA synthesis by epidermal growth factor and tumor promoters. Journal of Cellular Physiology. 108: 417-25. PMID 6270169 DOI: 10.1002/Jcp.1041080316  0.617
Show low-probability matches.